EVENTS

2017 ARIZONA ALZHEIMER’S CONFERENCE SCIENTIFIC CONFERENCE

2017 ARIZONA ALZHEIMER’S CONFERENCE SCIENTIFIC CONFERENCE

May 18, 2017

 

 

NeuroTech Conference – San Francisco

NeuroTech Conference – San Francisco

31st May – 1st June 2017

Eyal Baror will speak in this conference – Wednesday, May 31 10:40 – Treatments for Alzheimer’s and Cognitive Disorders

Globally, the population continues to age and the number of dementia patients keeps expanding. Ongoing efforts to develop disease modifying therapies have been plagued with failures. What new avenues are being pursued to address the growing global need? Will novel diagnostics allow us to initiate treatments earlier? What non-pharmacological options are in development?

Panelists: Casey Lynch, CEO, Cortexyme
Mark Gurney, CEO, Tetra Discovery Partners
Eyal Baror, CEO and President, Neuronix

 

 

Alzheimer’s London – Alzheimer’s Manchester

June 9-10, 2017  |  June 23-24, 2017

London
Stand: E3 Neuronix manufactures and markets the neuroADTM System, an innovative, non-invasive, medical device for the treatment of Alzheimer’s. NeuroADTM is the only non-pharmaceutical, CE-approved treatment in the UK that has been proven to improve cognitive function and help regain lost skills, with no side effects. With Neuronix, impacting Alzheimer’s is possible

Manchester
Stand: B7 Neuronix manufactures and markets the neuroADTM System, an innovative, non-invasive, medical device for the treatment of Alzheimer’s. NeuroADTM is the only non-pharmaceutical, CE-approved treatment in the UK that has been proven to improve cognitive function and help regain lost skills, with no side effects. With Neuronix, impacting Alzheimer’s is possible.